Stay updated with breaking news from Amanda Sheldon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
WESTLAKE VILLAGE, Calif., April 25, 2023 -- Arcutis Biotherapeutics, Inc. , an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in... | April 25, 2023
FDA has set a target action date of December 16, 2023NDA supported by positive efficacy and safety data from the Phase 2 and pivotal Phase 3 trials of roflumilast foamIf approved, roflumilast foam... | April 18, 2023
New INTEGUMENT-1 and INTEGUMENT-2 data show a rapid and significant reduction in itch as early as 24 hours after the first application of roflumilast cream...
12.12.2022 - Study met the primary endpoint and key secondary endpoints, consistent with positive topline results from the INTEGUMENT-1 trial released in NovemberFor the primary endpoint, 28.9% of individuals treated with roflumilast cream 0.15% achieved ...
25.10.2022 - WESTLAKE VILLAGE, Calif., Oct. 25, 2022 (GLOBE NEWSWIRE) - Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early-stage commercial company focused on developing meaningful innovations in immuno-dermatology, today announced that it will host a ...